Virtus Fund Advisers’s AtriCure ATRC Stock Holding History

Virtus Fund Advisers’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-810	Closed	-$18.4K	–	111
2024 Q2	$18.4K	Buy	810 +58	+8%	+$1.34K	0.07%	109
2024 Q1	$22.9K	Hold	752	–	–	0.08%	101
2023 Q4	$26.8K	Buy	+752	New	+$28K	0.17%	93
2014 Q3	–	Sell	-2,338	Closed	-$43K	–	1218
2014 Q2	$43K	Buy	+2,338	New	+$38.9K	﹤0.01%	1965

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Virtus Fund Advisers's ATRC Position: Q3 2024 in Review

Virtus Fund Advisers sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 810 shares — an estimated $18.4K sold.

Virtus Fund Advisers first reported a position in ATRC in Q2 2014 and held it in 4 quarters. The position peaked at $43K in Q2 2014. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

Virtus Fund Advisers reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
Virtus Fund Advisers sold 810 AtriCure shares in Q3 2024, an estimated $18.4K.
Virtus Fund Advisers first reported a position in AtriCure in Q2 2014 and held it in 4 quarters.
Virtus Fund Advisers's AtriCure position peaked at $43K in Q2 2014.
201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Virtus Fund Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.